Syndax Pharmaceuticals SNDX
NASDAQ SNDX
$13.15 -0.10 (-0.75%)
At close: Oct 21, 2026 · 4:00 PM EDT

Syndax Pharmaceuticals (SNDX) Finished Goods (2024 - 2026)

Updated

Syndax Pharmaceuticals (SNDX) recorded Finished Goods of $1.53 million in Q2 2026, down 31.9% from $2.25 million a year earlier but up 10.5% from the prior quarter.

Analysis

Syndax Pharmaceuticals (SNDX) Finished Goods (2024 - 2026) Analysis & Trends

At the end of FY2025, Syndax Pharmaceuticals reported Finished Goods of $1.62 million.

  • Across earlier years, Finished Goods came in at $36,000 in FY2024.
  • Quarterly Finished Goods has ranged from $36,000 in Q4 2024 to $2.35 million in Q1 2025 over the past five years.
  • Per Business Quant, the preceding three quarters came in at $1.38 million (Q1 2026), $1.62 million (Q4 2025) and $2.22 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Syndax Pharmaceuticals 1.17 Bn -558.85 Mn 69.58 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.53 Mn
Mar 31, 2026 1.38 Mn
Dec 31, 2025 1.62 Mn
Sep 30, 2025 2.22 Mn
Jun 30, 2025 2.25 Mn
Mar 31, 2025 2.35 Mn
Dec 31, 2024 36,000.00
API Access

Syndax Pharmaceuticals Finished Goods API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=finished-goods&ticker=SNDX&period=max&api_key=YOUR_API_KEY